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1Report of a FAO Expert Working Group
Section 1:
Background
The determination of protein requirements for human nutrition was reviewed by FAO for the fi rst 
time in 1955 (FAO, 1957) and subsequently in 1963 and 1971 with the World Health Organization 
(WHO) (FAO, 1965 and FAO, 1973); 1981 with WHO and United Nations University (UNU) (WHO, 
1985) and most recently in 2002 with WHO and UNU (WHO, 2007).   Separate but related expert 
meetings on protein quality evaluation were held in 1989 with WHO (FAO, 1991) and by FAO in 
2011 (FAO, 2013).  
In regards to protein quality evaluation, the 1989 Expert Consultation focused its attention 
on the then newly developed PDCAAS (Protein Digestibility Corrected Amino Acid Score) method 
for evaluating protein, while the 2011 Expert Consultation reviewed extensively the more recent 
DIAAS (Digestible Indispensable Amino Acid Score) method and considered the advantages and 
disadvantages for advocating the replacement of PDCAAS with DIAAS.   DIAAS measures the oro-
ileal nitrogen balance by calculating the ileal digestibility of individual amino acids.   In contrast, 
PDCAAS uses crude faecal digestibility values in measuring the oro-faecal nitrogen balance which 
includes contributions from intestinal secretions and colonic bacteria, thus underestimating the 
protein available for absorption.  
While there was consensus at the 2011 consultation that ileal digestibility was superior 
conceptually to faecal digestibility, there was concern about whether there was suffi cient published 
data available on true ileal amino acid digestibility on a wide range of human diets to allow the 
practical implementation of a system based on ileal digestibility.   In addition, whereas substantial 
ileal amino acid digestibility data had been collected from pigs and rats using a standardised 
methodology for the sampling of ileal content, there was concern that the foods used were not 
representative of human diets including those in developing countries and that animal digestibility 
values were representative of those of humans.   In order to address these concerns, the 2011 
consultation established 2 subcommittees tasked to report after the formal consultation had 
fi nished but before the report was completed.  The fi rst subcommittee was tasked to collate all 
available human and animal ileal digestion data, while the second subcommittee was to evaluate 
this collated data to establish whether it was suffi cient to warrant replacing PDCAAS with DIAAS 
as the preferred method at this time.  The second subcommittee concluded that:
“… currently available data were insuffi cient to support the application in practice….of true 
ileal amino acid digestibility in the calculation of DIAAS”, and that “more data on the true 
ileal amino acid digestibility of human foods was urgently needed, determined in humans and 
animal models” (FAO, 2012a).  
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The overall outcome of the Expert Consultation was that “More inter-species (human, pig, 
rat) true ileal amino acid digestibility comparisons are urgently needed” (FAO, 2013) and it was 
recommended that FAO organize and convene an expert working group:
“…to agree upon an experimental protocol to enable the development of a more robust data 
set of the true ileal amino acid digestibility of human foods...” and that “The protocol should 
include recommended best practice for a pig-based assay for true ileal amino acid digestibility 
determination” (FAO, 2013).  
In addition, the second subcommittee recommended that: 
“If the data obtained from these studies (as specifi ed under #3) convincingly support the move 
to ileal digestibility, assessment of the potential impact of this recommendation (to be used in 
the assessment of individual protein sources as well as mixed diets commonly consumed by 
humans) needs to be undertaken before the new evaluation model is implemented.  This should 
include potential gains and/or losses to public health consequent upon the implementation 
of the new recommendations on the assessment of protein quality for humans” (FAO, 2012a). 
Subsequently, recognizing the diffi culties of obtaining human ileal digestibility values directly 
and in light of the increased application of stable isotopes in determining protein utilization, 
FAO expanded the working group’s topic “to provide recommendations on the best methods to 
measure and predict digestion and effi ciency of utilization of protein and amino acids in humans” 
(See Annex 6).
Planning for the working group began in mid-2013 soon after the Expert Consultation 
report was published.  A fi rst call for experts was announced in August 2013 but due to an 
insuffi cient number of responses from qualifi ed scientists and the expanded topic, a second call 
was announced in December 2013.  The 25 applications received were reviewed by two non-FAO 
scientists who were not directly involved in the working group planning.  They each ranked the 
applicants according to the criteria based on the description in the call for experts.  FAO invited 
the experts who received the highest rankings to attend this working group.  
Each expert was requested to fi ll in a declaration of interests.  Of the 10 experts, 6 gave 
information regarding advisory activities with a range of organizations that may have interests 
relevant to the working group topic.  However, FAO did not fi nd that the activities represented a 
potential competing interest that would warrant exclusion of any of the experts from the working 
group focusing on research methodologies.
FAO provided the complete funding for the expert working group meeting through a letter 
of agreement with the St.  John’s Research Institute in Bangalore, India, an integral part of the 
St.  John’s National Academy of Health Sciences, which hosted and organized the logistics for the 
meeting.  
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Section 2:
Introduction and Opening of the Working 
Group Meeting
The meeting was held at the St. John’s Research Institute (SJRI), an IAEA Collaborating Centre, 
in Bangalore, India, from 2 to 5 March 2014.  The opening welcome on behalf of the SJRI was 
given by Dr. Anura Kurpad, followed by a welcoming statement on behalf of FAO by Dr. Warren 
T K Lee.  Subsequently, those in attendance introduced themselves and briefl y described their 
research focus and its relationship to the objectives of the working group.  Dr. Janice Albert of FAO 
introduced and explained the draft agenda and the plan for conducting the meeting (See Annexes 
4 and 5).  The introductory session was concluded by Dr. Robert Weisell with a presentation on 
the history of FAO’s involvement with protein requirements and protein quality evaluation and a 
second presentation by Dr. D J Millward giving a perspective on methods for determining protein 
quality which was based largely on an article in the British Journal of Nutrition (Millward, 2012).
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Section 3:
Rationale for the Working Group Meeting 
Following the opening and introduction of the participants, the working group reviewed 
the aim of the meeting, which originated from the FAO Expert Consultation in 2011. 
Dr. Paul J Moughan, the chair of the 2011 FAO Expert Consultation on Dietary Protein Quality 
Evaluation in Human Nutrition provided an overview of salient points from the consultation for 
this working group’s attention.  These were: 
1. Identify one or more experimental protocols to enable the development of a more robust 
data set of the true ileal AA digestibility of human foods; this would include more data on 
true ileal AA digestibility and more inter-species comparisons of true ileal AA digestibility.
2. The protocols should include recommended best practice for pig-based, rat-based and 
adult human-based assays of true ileal AA digestibility.
3. Direct measures of amino acid bioavailability and utilization often involving stable isotopes 
are being developed.  These offer additional information about protein quality and should 
be considered for further development.
The participants discussed the review and sought clarifi cation on some issues.  One expert 
disagreed with the word ‘true’ digestibility and preferred the term ‘standardised’.  The group 
acknowledged there was a need to clarify the nomenclature (e.g. apparent, true, real, standardised) 
and suggested it as an item for future work.
Two experts who had also attended the 2011 FAO Expert Consultation drew attention to the 
report of the second subcommittee of the Expert Consultation, which was prepared following 
the Expert Consultation meeting in New Zealand (FAO, 2012a).  This subcommittee assessed the 
advisability of using ileal digestibility over faecal digestibility and based largely on the report 
from the fi rst subcommittee found that there was insuffi cient human ileal digestibility data to 
accommodate a change from true faecal crude protein digestibility (PDCAAS) to true ileal amino 
acid digestibility (DIAAS) at the time (FAO, 2012b).  Further, the public health impact of this 
change in the way of evaluating protein had not been assessed.  Attention was then given to the 
current working group task.
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Section 4:
Protein Quality Evaluation and Public 
Health Considerations
The objective of the working group meeting was to bring together experts in the area of protein 
and amino acid nutrition to update our knowledge of the science related to protein and protein 
quality evaluation.  However, the experts recognized the relevance of protein quality in addressing 
nutrition and public health and its effect on health and nutrition outcomes, a topic on which 
Dr. Ricardo Uauy made a presentation. 
All aspects of protein’s physiological role are of key importance in defi ning its impact on 
health and functional outcomes since the absolute amount of protein in itself does not refl ect 
the true and total nutritional effects.  Of primary importance is protein quality.  Important body 
functions such as immunity and host defenses, linear growth and associated mental development 
are affected by protein quality.  Recently, these topics were discussed in full at a workshop held 
in the spring of 2012 at Tufts University with the proceedings published in a special section of the 
Food and Nutrition Bulletin (FNB, 2013).
Recent literature indicates that protein quality and not only quantity is of importance to support 
linear growth and reduce stunting of children (Ghosh et al., 2012; Timby et al., 2014; Uauy, 2013) 
and mental development and performance of children (Steinberg et al., 1992; Yogman et al., 
1982).  Specifi c attention has been given to the effects on infant growth and development due to 
changes in infant feeding (Heine, 1999; Heine et al., 1996; Jackson et al., 2002; Lien, 2003; Lien 
et al., 2002; Markus et al., 2000; Markus et al., 2002) and the precursor roles of specifi c amino 
acid such as tryptophan in regards to serotonin (Borbély and Youmbi-Balderer, 1987; Fernstrom, 
2012; Fernstrom, 2013; Fernstrom and Fernstrom, 1995; Fernstrom et al., 2013; Sharp et al., 1992; 
Yogman et al., 1982) and tyrosine in regards to adrenaline and noradrenaline.  Moreover, the 
evidence produced over the past decade indicates that improved linear growth is associated 
with lower risk of death during childhood and to enhance educational performance and labour 
productivity later in life.  A long-term follow up of 5 cohorts from developing countries that 
included as outcomes linear growth, educational performance and adult productivity revealed 
a signifi cant effect of stunting on restricting educational attainment which was associated with 
lower adult income levels (Hoddinott et al., 2008).  In one of the countries, Guatemala, a protein 
and energy supplement was compared to providing only energy; the results related to adult 
productivity indicated that the protein-energy supplemented group achieved a higher level of 
education and greater income in adult life.  These follow up studies have indicated the need to 
improve the quality of foods considering linear growth and not weight as the relevant short term 
outcome that will impact adult productivity and long term health.  The policy implications of these 
fi ndings point to the fi rst 1000 days (from conception to age 2 years) as the critical time for long 
term benefi ts for health, productivity and well-being of populations.
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Section 5:
Relationship Between Animal and Human 
Studies and Bridging the Two
The working group was faced with the question “What would legitimize the use of animal 
experimental results for the application to humans?” It was agreed that there were limitations 
with both the animal and human methods.  However, the goal was to address and accommodate 
these limitations. 
While recognizing that human data are preferable, the 2011 Expert Consultation recommended 
that the initial routine evaluation of human foods would be more immediate by using the fully 
validated true ileal amino acid digestibility (TID) assay in the growing pig.  The working group 
believed that the digestive and nutrient absorption systems of the pig is somewhat comparable 
to humans physiologically, although not totally.  The pig models offered opportunities to develop 
relatively rapidly large data sets of the ileal digestibility of amino acids in a large number of 
human foods since the methods have been standardised worldwide.  However, the working group 
stressed that validation studies further to those already published were needed to confi rm the 
use of pig data sets to represent the digestibility of the same foods when consumed by humans. 
In addition, the generated data could be assumed to apply to healthy adult humans but not 
necessarily to human subjects with specifi c conditions (e.g. disease, age, under nutrition, tropical 
enteropathy/malabsorption, parasite burden, pregnancy and lactation). 
Recently developed, direct in vivo isotopic methods for determining amino acid digestibility show 
great promise.  In developing the isotopic method for determining amino acid digestibility in humans, 
direct comparison should be made with data from the pig-based true ileal amino acid digestibility 
assay.  For example, with the Indicator Amino Acid Oxidation (IAAO) and the Net Postprandial 
Protein Utilization (NPPU) assays giving estimates of digestibility of the limiting amino acid in a 
dietary protein, it is likely that such a comparison can be undertaken in the near future.  The experts 
recommended that research be conducted to compare the IAAO and the NPPU estimates of a limiting 
amino acid bioavailability in humans and pigs with the pig true ileal amino acid digestibility assay of 
the specifi c amino acid.  There should also be bridging between other potentially more convenient, 
but at present theoretical isotope methods for determining amino acid digestibility that are 
being developed, by comparison with the true ileal amino acid digestibility assay in the growing 
pig.
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1 Bioavailability encompasses three properties of foods that can alter the proportion of an amino acid that can be 
utilized; these are:
1. Digestibility, which describes the net absorption of an amino acid.
2. Chemical integrity, which describes the proportion of the amino acid that, if absorbed, is in a utilizable form.
3. Freedom from interference in metabolism resulting from the presence in the food of substances that limit the 
utilization of the amino acid.
Of these, the greatest source of variation in bioavailability is, in most cases, digestibility.
Section 6:
Characteristics of an Ideal Method of 
Protein Quality Evaluation
Prior to the discussion of the different methods currently available and developing research 
protocols, one expert proposed a framework for the development of any new method for 
evaluation of protein quality.  This was presented with a challenge as to what would be the 
characteristics of an ‘ideal’ method for determining the bioavailability of amino acids (protein 
quality) in humans.  
As a starting point, the defi nition of bioavailability described in the report of the 2011 FAO 
Expert Consultation (FAO, 2013) was accepted for this purpose1.  The goal was to establish a list of 
characteristics and parameters that could be used to guide the decision regarding the suitability 
and potential application of the available methods under consideration and methods that may be 
developed in the future.
The fi rst and most important characteristic was that the ideal method would allow for direct 
measurement in humans.  This was recognized, however, as potentially diffi cult to achieve due to 
the scarcity of non-invasive methods of measurement and ethical considerations.  Thus, methods 
applicable to animals could be considered as long as suffi cient cross-species comparison research 
was conducted to develop acceptably accurate predictions of amino acid bioavailability in humans. 
The ideal method would also be directly applicable in all human life stages and conditions 
that could possibly affect the digestion, absorption, and metabolism of amino acids, and thus 
bioavailability.  These human conditions would include: inter alia, age, health status, genetics, 
environment, prior nutritional status, parasitism and other conditions.
To be relevant to actual conditions, the method must be applicable to the widest possible range 
of human foods.  From the perspective of public health, this would mean the inclusion of foods 
of low protein quality (e.g.  pulses and grains), which represent common protein sources for the 
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poor.  In addition, it must be able to capture the effects of a wide range of cooking and processing 
methods on protein bioavailability.  Cooking and processing methods are known to produce anti-
nutrient factors such as the Maillard-type reaction products, which reduce lysine bioavailability, 
and may also reduce bioavailability of other amino acids through a range of possible reactions 
with starch, sugars or mineral components of the diet.
Of critical importance is the ability to measure the bioavailability of all individual amino acids. 
However, not all methods may capture data on all amino acids.  For example, methods that 
measure changes in postprandial net protein synthesis may work well for an individual limiting 
dietary indispensable amino acid (IAA), such as lysine in most cereals, the sulfur amino acids in 
legumes and tryptophan in maize, but would not be applicable to all IAAs or to dispensable amino 
acids (DAA).  Since indispensable amino acids are of greatest importance, the fi rst priority would 
be given to research on those indispensable amino acids that are most likely to be limiting for 
humans in that particular food, with fi rm recognition that the dispensable amino acids are also 
important in human nutrition and require consideration wherever possible.  
Any method chosen must also be applicable to mixed human diets and be capable of 
measuring the effect of amino acid supplementation.  Where the overall protein quality of a 
foodstuff, or a traditional mixed diet, is lowered because of the low bioavailability of a single 
amino acid, enhancement of the food with protein sources supplying the limiting amino acid or 
supplementation with the limiting amino acid can dramatically increase the capacity of the food 
or diet to meet protein and amino acid requirements for human growth, performance and health. 
Therefore, it would be desirable if the method could detect or measure or be used to calculate the 
effect of complementation or amino acid supplementation on overall quality of the diet.  
Any method chosen must allow for wide implementation because this is necessary to create 
a large enough database of local foods and food processing/cooking methods to justify changing 
global recommendations.  In this context, wide implementation means that the method must 
be applicable to a large range of potential users, i.e. research institutions and governments and 
industry with various levels of skill and background knowledge.  This implies that the method 
should be understandable by these groups and the methodology clearly defi ned so that the 
introduction of errors is unlikely.  
A signifi cant consideration for wide implementation is that the cost must be reasonable; 
otherwise, the method is not feasible.  In addition, if used directly in humans, the method should 
be minimally invasive; otherwise, recruitment of research subjects and approval by relevant 
human ethics committees becomes a potentially limiting factor.  
A clear recognition of the 2011 Expert Consultation was that there is a very limited quantity 
of ileal amino acid digestibility data directly obtained in humans and therefore, any methods 
should be validated in animals as far as is possible.  This means that the results obtained with the 
method must be comparable to very well described and widely accepted methods in amino acid 
ileal digestibility (True Ileal Digestibility, i.e. TID or Standardised Ileal Digestibility, i.e. SID) and 
bioavailability in animals and must give similar results to these methods.  
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Finally, it would be advantageous if the method could be potentially recognized and accepted, 
as a minimum, by the Codex Alimentarius Commission.  This means that the method would gain 
wide acceptance and could be used potentially by food regulatory agencies in evaluating food 
health and nutrition claims by industry.  
The Working Group concluded that the ‘ideal’ method does not currently exist in that no 
method meets all the criteria.  Therefore, the Working Group proposed that a combination of the 
existing methods may be required, for example, the combination of pig TID measurement with 
IAAO.  Different methods may also be required depending upon the specifi c research goals or 
foodstuffs.  Ultimately, the goal is to accumulate suffi cient data to enable the practical change 
from the PDCAAS to the DIAAS approach for assessing the protein quality of human foods and 
diets.
What would be the components of an “ideal” method for bioavailability of amino acids in 
humans? 
• Direct measurement in humans.  If not possible, need suffi cient cross-species research to 
develop predictions from animal research;
• Directly applicable in all human life stages (i.e. age), health status, genetics, environment, 
nutritional status, other conditions;
• Applicable to wide-range of human foods and must capture effects of cooking and other 
technological processes applied to foods;
• Applicable to all individual amino acids.  Give priority to indispensable amino acids (IAA) 
but desirable to include dispensable amino acids (DAA) or sum of DAA;
• Applicable to mixed human diets and supplementation;
• Must be capable of wide implementation because this is necessary to create a large 
enough database of local foods and food processing/cooking methods to justify moving 
worldwide recommendations.  
– Cost must therefore be reasonable if wide implementation is to be feasible; 
– Should be minimally invasive because this is desirable/necessary for wide 
implementation; 
– Validated in animals – values agree with well-described and accepted methods in 
amino acid digestibility (SID) and bioavailability.
• Potentially recognizable at least to the Codex Alimentarius Commission (CODEX).  
The working group adopted this framework as a starting point for evaluating and developing 
several research protocols that could be used alone or in combination.  In addition, the various 
methods could be part of a coordinated international effort to provide evidence in support of the 
effective future use of DIAAS.
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Section 7:
Methods for Measuring Protein 
Digestibility in Human Foods
The Working Group considered fi ve protocols that were either well-tested and used or showed 
considerable promise with future development.  These are described in subsections 7.1 to 7.5 and 
include:
• True Ileal Amino Acid Digestibility
• Indicator Amino Acid Oxidation (IAAO)
• Postprandial Protein Utilization (PPU)
• Net Postprandial Protein Utilization (NPPU)
• A Dual Tracer Approach to Measuring DIAAS
Because these methods encompass a range in the state of development, varying levels of 
prescription and details can be provided.  For the initial three methods, suffi cient information 
is available for providing either extensive detail as to how to apply the method or caution and 
advice (See Annexes 1, 2 and 3).
7.1 TRUE ILEAL AMINO ACID DIGESTIBILITY
The 2011 FAO Expert Consultation concluded that presently it is diffi cult and expensive to 
determine true ileal amino acid digestibility directly in humans.  Therefore, there was a need for 
an animal model for the more routine determination of amino acid digestibility.
It was agreed that the rat, being a nocturnal animal with a selective feeding habit and 
practicing coprophagy, is an inferior animal model to the pig, which is a meal-eating omnivore 
with a similar anatomy of the digestive tract (mouth to ileum) and similar digestive physiology to 
the adult human.
The similarities between the growing pig and adult human for protein and amino acid 
digestibility are well documented.  Pig true ileal amino acid digestibility and ileal reactive lysine 
digestibility measures have been thoroughly validated in pig studies and have been shown to 
be accurate predictors of absorption in this animal.  Published studies (based on four protein 
sources) show close inter-species agreement between growing pigs and the adult human for true 
ileal amino acid digestibility (Deglaire et al., 2009a; Rowan et al., 1994).
With rats, foods need to be fi nely ground before presentation to the animal to avoid particle 
selection by the animal, whereas the pig will generally consume foods eaten by humans and in 
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the form presented to humans for consumption.  The fi ne grinding of foods for rats is likely to 
infl uence nutrient digestibility.  Advantages of the pig as an animal model for the prediction of 
amino acid digestibility in humans were noted as:
• Excellent control and standardisation possibilities;
• Pig provides large samples of ileal digesta;
• All amino acids can be determined in a single assay;
• Pigs eat a wide variety of foods including virtually all foods consumed by humans;
• The availability of laboratories able to conduct pigs assays.
• Limitations of the pig model include its cost; possible future constraints of animal use due 
to ethical considerations.  
Further, although the process of protein digestion in the pig is physiologically similar to that in 
humans, protein digestibility is unlikely to be identical.  While not refl ecting on the determination 
of protein quality in optimal conditions per se, there is the further public health consideration 
of determining the effect that different social and environmental conditions could have on the 
recommended protein quality of human diets.  The human condition may be quite variable due to 
malnutrition, exposure to parasites and tropical enteropathy, etc.  Consequently, the digestibility 
of amino acids in humans is likely to be variable and the determination of whether an additional 
allowance for protein quality is needed will require a measurement that can be used in humans 
in these conditions.
Consideration was given to developing robust statistical prediction equations relating protein/
amino acid digestibility determined in the adult human with that determined in the growing pig. 
Such a relationship has been published (see Figure 1), but it was considered by the Working Group 
that this dataset should be expanded and extended by the addition of experimental results for 
additional protein sources, particularly covering protein sources with a low (<75%) and a medium 
(<85%) true ileal nitrogen and amino acid digestibility.  Aspects of developing standardised 
protocols for the determination of true ileal amino acid digestibility (naso-ileal intubation for 
the adult human given liquids and powdered materials; adult human ileostomates for coarser 
materials, cannulated growing pig, laboratory rat) were discussed and subsequently developed 
(See Annex 1)
Figure 1: Human-growing pig comparison
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Once the relationship for true ileal amino acid digestibility between pigs and humans has 
been developed over a wider range of digestibility values, application of the pig true ileal amino 
acid digestibility protocol should be encouraged to develop a complete dataset of the amino 
acid digestibility of human foods.  The Working Group concluded that it would be valuable to 
strengthen the relationship of true ileal amino acid digestibility values between pigs and humans, 
based on a wide range of foods and diets, thus potentially broadening the application of the data 
base.  
7.2 THE INDICATOR AMINO ACID OXIDATION (IAAO) METHOD 
Background
The IAAO method was discussed at the 2011 Expert Consultation (FAO, 2013).  Because it is one 
of only 2 published bioassay methods in humans that produce data on amino acid bioavailability 
in humans, it was considered in detail at the working group meeting in 2014.
The IAAO method has been used extensively to measure the amino acid and protein 
requirements of pigs (e.g. Ball and Bayley, 1986; Moehn et al., 2008) and humans (see 
reviews by Elango et al., 2009, 2012a, 2012c; Pencharz and Ball, 2003).  The most recent 
protein requirement report (WHO, 2007) noted the potential promise of using 24-hour IAAO 
balance instead of or in addition to 24-hour nitrogen balance for the determination  of amino 
acid requirements of humans.  A method, based upon the IAAO technique, was developed 
to measure the metabolic availability of the limiting amino acid in the diet of pigs (Levesque 
et al., 2010; Moehn et al., 2005, 2007) and subsequently adapted to humans (Humayun 
et al., 2007, Prolla et al., 2013).  In the pig, the values obtained by IAAO are not different from 
those obtained by ‘true’ ileal digestibility.  The term ‘metabolic availability’ was coined to describe 
the sum of the overall digestion, absorption and metabolic utilization for protein synthesis of 
amino acids from the dietary protein source.  This is accepted as equivalent to the defi nition of 
bioavailability used in the report of the 2011 FAO Expert Consultation (FAO, 2013).  The digestibility 
of the amino acid will have the largest infl uence on the IAAO response.  However, because this 
method measures a relative change in net protein synthesis, any amino acid in the food that is 
unavailable, due to chemical complexes such as Maillard reactions or reduced utilization due 
to interference from other factors in the diet or creation of un-reactive amino acid by cooking 
methods (e.g. effect of acid treatment on methionine and tryptophan), will be accounted for. 
The IAAO method is based on the fact that when any single amino acid is limiting for protein 
synthesis that all other amino acids are in excess and thus must be oxidized.  The indicator amino 
acid is maintained at a constant intake; therefore, the decline in IAAO is linear with incremental 
addition of the limiting amino acid below the requirement intake.  Therefore, this portion of the 
response can also be used to test the change in net protein synthesis with increasing intake of a 
food ingredient in which an amino acid is limiting.  
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Calculation of bioavailability in IAAO experiments
The slope of the oxidation line for increments of the food compared to the slope of the oxidation 
line for the same amino acid supplied as a 100% bioavailable synthetic amino acid allows a slope 
ratio calculation (Batterham, 1992; Littell et al., 1997).  The slope of the oxidation obtained with 
the crystalline form of the test amino acid represents the maximal unit increase in net protein 
synthesis and is equivalent to 100% bioavailability of the test amino acid.  A shallower slope 
indicates that less amino acid per unit intake is available to support net protein synthesis.  The 
ratio of the slopes therefore represents the bioavailability of the limiting amino acid in the food. 
Figure 2 demonstrates the typical response as reported by Moehn et al., 2007.
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Figure 2: Lysine availability in peas
The bioavailability of the amino acid is calculated by the slope ratio method as oxidation 
change per g protein bound amino acid divided by oxidation change per g free amino acid, using 
the following equation: 
y = a + bSxS + bTxT 
where xS and xT stand for the levels of intake for the standard and test sources respectively and 
bS and bT are the slopes for the standard and test sources respectively (Littell et al., 1997).  The 
bioavailability of the test source is then calculated as bS/bT.
There are several advantages to this slope ratio approach for this calculation.  Because the 
measured response is a relative change, rather than an absolute value, this will reduce the effect 
of inter-laboratory variability.  It also means that differences in rates of net protein synthesis 
among the subjects will have no infl uence because individuals are used as their own controls.  
There are a number of key conditions that must be satisfi ed for correct use of IAAO and the 
slope ratio assay for amino acid bioavailability.  A description of these may be found in Annex 2.
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Choice of indicator Amino Acid
The choice of indicator amino acid and the essential and recommended characteristics of an 
indicator amino acid have been discussed frequently in publications (e.g. Elango et al., 2012b; 
Levesque et al., 2010; Zello et al., 1993) and are critical to sensitively partition the response 
to graded test intakes between protein synthesis and oxidation.  The criteria for selecting the 
indicator amino acid are: a) it must be an indispensable amino acid; b) it must have a carboxyl-
labeled carbon that is irreversibly oxidized upon catabolism and is released to 13CO2, which can 
be quantitatively measured in breath; c) it must have a small, well regulated pool within the 
body and d) it is not involved in quantitatively signifi cant pathways other than incorporation 
into protein or oxidation to CO2.  Phenylalanine, in the presence of excess tyrosine, fi ts all four 
criteria.  L-1-13C-Phenylalanine has been successfully used to measure metabolic availability in 
pigs (Levesque et al., 2011; Moehn et al., 2005, 2007) and humans (Humayun et al., 2007; Prolla 
et al., 2013).  It is possible that other amino acids, such as leucine, are usable as tracers; however, 
to date phenylalanine has been used in these protocols to determine dietary bioavailability of 
amino acids.  
IAAO methodology for establishing the necessary linkage between the 
Pig TID database and Human Foods
To bridge the data from the human IAAO results on bioavailability to the pig TID database, 
corresponding IAAO experiments for bioavailability must be conducted in pigs as described 
by Moehn et al., 2007.  Initially, this must be conducted with a suffi ciently large number of 
foods with a wide range in amino acid bioavailability so that robust prediction equations can 
be developed.  Thereafter, this step need only be conducted for foods that have characteristics 
or bioavailability outside of the reference range of foods used in the fi rst instance to develop 
corrections or adjustments to the pig TID database.  If doubt exists about the accuracy of the 
correction factor used for any type of food studied by human IAAO bioavailability, then a pig IAAO 
experiment for bioavailability is required.  
Critique of protocol and conclusions
The IAAO bioavailability method, which is based on minimal assumptions that have been validated 
in animals and humans, can be used to assess all protein sources and measures the bioavailability of 
individual amino acids.  It is a relatively non-invasive method, requiring only the oral consumption 
of the food and stable isotope and collection of breath samples for analysis of 13CO2; it is therefore 
readily adaptable to routine use for evaluation of amino acid bioavailability of proteins in human 
nutrition in a variety of human conditions in multiple countries.  The method produces similar 
values for amino acid bioavailability in the pig for lysine, threonine and methionine as the more 
invasive true ileal digestibility (TID) pig method.  Technically, the method is based on measures 
of overall amino acid utilization and therefore, meticulous control is necessary as any factor that 
differentially affects utilization of the amino acid from the test diet versus the reference diet will 
affect the outcome.  This method has also been tentatively applied to humans but some additional 
method development work may be necessary in humans to ensure that very similar methods are 
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used in both pigs and humans (see “IAAO methodology - humans” section in Annex 2).  Assuming 
such developments, this method will be able to provide the necessary correction or adjustment 
factors for bridging the TID pig results to the human model.  To accomplish this, the identical IAAO 
metabolic availability experiments need to be conducted in both pigs and humans using a range 
of identical foods and compare these to the TID pig method.  The drawback of the IAAO metabolic 
availability method is that it only measures availability of a single amino acid in the course of 
an experiment.  Therefore, multiple experiments would be required for each food.  The Working 
Group endorsed the IAAO method and encouraged further research in humans and the proposed 
experiments to conduct the necessary comparisons of pigs and human results described above. 
Of immediate importance would be increasing the number of data points representing various 
diets and foods of varying degrees of digestibility.
7.3 POSTPRANDIAL PROTEIN UTILIZATION (PPU)
Background
The PPU assay was developed to determine the overall effi ciency of protein utilisation in the 
postprandial state (see Gibson et al., 1996; Millward, 1998, 2003, 2012; Millward and Pacy, 1995; 
Millward et al., 2000, 2002 for a detailed discussion of the limitations of the 13C-1 leucine infusion 
approaches and of the metabolic model involved).  The approach involves measurement of 13C-1 
leucine oxidation and balance in response to feeding during a constant infusion of trace amounts 
of 13C-1 leucine.  The change in leucine balance as a proportion of the change in leucine intake 
represents a value for the effi ciency of post prandial protein utilisation (PPU) similar to net protein 
utilization (NPU) but will produce more realistic values than those from slope of nitrogen balance 
studies which have been argued to underestimate protein utilization (Millward, 2003; Millward, 
2012).  
The procedure included two protocols.  In each one, leucine balance (leucine intake - leucine 
oxidation) is converted to nitrogen balance on the basis of leucine - nitrogen conversion factors 
for tissue protein and this is compared with the actual meal nitrogen intake.  
The fi rst protocol (Millward et al., 2000) is a steady state, two intake slope assay, consisting 
of three consecutive 3-hour periods of fasting, low protein feeding and high protein feeding 
during a constant intravenous (IV) infusion of 13C-1 leucine.  Both the low protein (LP) and high 
protein (HP) diets are consumed in small meals at 30 minute intervals in an attempt to achieve 
a metabolic steady state.  For such a protocol with both the LP and HP meals being isoenergetic, 
the PPU is infl uenced only by the protein intake (insulin levels are unchanged during the two 
feeding phases) and is calculated from the slope of the N balance curve between the LP and HP 
meal feeding: 
PPU = NB/NI
The second protocol (Millward et al., 2002) is a non-steady state, area under the curve (AUC) assay 
also involving a 9-hour iv 13C-1 leucine infusion protocol.  In the case of this protocol, a single 
meal is fed after the initial 3-hour infusion in the fasting state and the cumulative increase in 
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leucine oxidation above the basal post-absorptive state is measured over the six hours following 
the meal to give nitrogen utilisation, determined by N intake - cumulative excess N excretion. 
With this protocol, PPU is infl uenced by both the protein and energy component of the meal with 
the energy intake increasing insulin and suppressing proteolysis.  PPU is calculated from total 
excess leucine oxidation, AUC leucine oxidation above fasting level: 
PPU = N utilisation/NI
Both protocols produced similar PPU values for milk and wheat protein with the large meal values 
being slightly lower.  
Adaptation of protocol to assess digestibility
The issues discussed at the working group meeting prompted the question of whether this 
protocol could be adapted to assess the two components of protein quality, i.e. digestibility and 
biological value. 
In order to assess which of the two protocols is most sensitive to changes in digestibility, 
recalculation of the PPU value can be made using the observed leucine oxidation rates and varying 
values for digestibility.  In the case of the two protocols described above, the digestibility of the 
wheat protein was assumed to be 93%.  In Table 1 below, PPU values have been recalculated 
assuming digestibility levels of 100%, 93% (as in the published studies), 80% and 50%.  
Table 1: PPU values for wheat evaluated by the two protocols assuming different values for the 
digestibility of the wheat protein used in the studies
Assumed % Digestibility PPU Small Meal PPU Single Meal
100 0.71 0.64
93 0.70 0.62
80 0.68 0.55
50 0.60 0.28
The PPU calculation from the single meal protocol is much more sensitive to changes in 
digestibility.  This difference between the two methods refl ects the way that PPU is calculated 
in the two studies.  Although in each case both the intake and balance (intake-loss) terms in the 
calculation are infl uenced by assumptions of digestibility of the wheat, the multiple small meal 
steady state slope calculation (change in balance as a fraction of the change in intake) is less 
sensitive than the single large meal AUC calculation of absolute balance/intake calculation.  These 
results suggest that an assay based on the single meal AUC approach would be best suited to 
separately evaluate both the digestibility and biological value components of protein utilisation. 
Although the single meal protocol examines the sum of the effect of energy and protein on 
protein utilisation, it can be argued that this is more relevant in terms of physiology.  Thus, it is 
proposed that the single meal protocol be adopted for examining the digestibility levels.
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Suggested single meal assay of protein digestibility
The metabolic model as described by Millward, 2003 and Millward et al., 2002 is shown in 
Figure 3.  
Dietary protein provides for both obligatory and adaptive metabolic demands that occur 
throughout the diurnal cycle.  Leucine oxidation in the post absorptive state is assumed to trace 
overall amino acid oxidation and nitrogen excretion derived from tissue protein loss.  Meal protein 
is utilized to provide for obligatory and adaptive demands and for tissue gain associated with 
repletion of post absorptive losses.  Any increased leucine oxidation with feeding (meal-dependent 
oxidation measured as cumulative increased leucine oxidation) represents the ineffi ciency of meal 
protein utilization.  Postprandial protein utilization (PPU) is calculated from cumulative increased 
oxidation and nitrogen intake after conversion of utilized leucine into nitrogen to account for 
differences in meal and tissue leucine-nitrogen ratios.
To examine the protein quality, one must determine the digestibility of the protein, food or 
diet.  If the PPU of the protein or meal under test was compared with the PPU obtained with 
a meal of an amino acid mixture formulated to match the amino acid composition of the test 
protein, one can assume that any difference in PPU between the test protein and the amino acid 
mixture will be due to digestibility only.  Thus, the PPU of the free amino acid meal will refl ect 
biological value (amino acid score) whereas the PPU of the test meal will refl ect digestibility x BV: 
Such an assay allows a complete measure of the protein quality of the protein or mixed meal 
under test.  
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Critique of protocol and conclusions
As stated earlier, this method was developed for and to date has only been used to evaluate 
the biological value of the protein.  However, the description above offers a possible adapted 
protocol, which should allow the digestibility of either a single source protein or a mixed meal to 
be assessed with a reasonable degree of confi dence.  It has the advantage of also allowing the 
biological value and the overall protein utilisation to be assessed and an estimate of the protein 
requirement of a population group although it does not allow the digestibility of individual amino 
acids to be assessed.  It is stressed that the PPU value and digestibility measure obtained with 
the method is, like all the other proposed stable isotope methods including the IAAO and dual 
tracer methods, a measure of the whole body utilisation and actual digestibility in terms of entry 
of amino acids into the circulating metabolic amino acid pool rather than a measure of loss from 
the gut at any specifi c point (terminal ileum or anus).  Thus, it is a different approach to and not 
strictly comparable with either ileal or faecal values as measured in the pig assay.  
Its limitations are mainly: 1) the assumptions made in calculating leucine oxidation (see 
Gibson et al., 1996) in that the route of isotope delivery is intravenous and thus bypassing the 
small intestine and 2) in converting leucine balance to N balance, i.e. the leucine N ratios of the 
dietary intakes (which can be measured) and of tissue proteins (which can only be estimated). 
However, the extent of errors introduced by incorrect conversions factors can be easily calculated. 
Clearly, because this assay is not fi rmly established investigators may wish to modify it to suit 
their own purposes and may require additional research and development for determining the 
bioavailability of protein bound amino acids.  In addition although this approach as described 
involves developing an existing protocol so that it can measure both digestibility and biological 
value in human subjects, the same approach can in principle be applied to animal models where 
such studies were deemed appropriate.
7.4 NET POSTPRANDIAL PROTEIN UTILIZATION (NPPU)
Introduction
The nutritional effi ciency of dietary protein utilization is based on the extent to which the dietary 
protein nitrogen is absorbed and retained by the organism while balancing the daily nitrogen 
losses.  The net protein utilization is the percentage of ingested nitrogen that is retained in the 
body and is determined by measuring digestive, metabolic (urinary) and miscellaneous nitrogen 
losses.  As the post-prandial phase is a critical period of dietary protein utilization, net postprandial 
protein utilization (NPPU) which is the immediate retention of dietary nitrogen following meal 
ingestion represents a reliable and sensitive approach for the assessment of dietary protein 
nutritional effi ciency.  NPPU is a measure of protein quality that takes into account true ileal 
protein nitrogen digestibility and the fraction of absorbed dietary nitrogen that is retained in 
the body during the post-prandial phase.  NPPU is determined from the difference between total 
ingested dietary protein nitrogen corrected by true nitrogen ileal digestibility, and dietary protein 
nitrogen subjected to deamination and recovered in urea body pool and urinary nitrogen.  
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Description of method
Due to the presence of endogenous protein and amino acids, the NPPU approach uses a stable 
isotope-labelled dietary protein and AA to trace absorption and metabolic utilization of protein 
bound dietary amino acids (Fouillet et al., 2002a; Fuller and Tomé, 2005) and to differentiate it 
from the endogenous protein, amino acids and derived metabolites (particularly ammonia and 
urea) already present in the intestinal lumen and in the blood.  
There are a number of ways to intrinsically label proteins with stable isotopes, all of which are 
reported in the literature (for instance, Bos et al., 2005, 2007; Fromentin et al., 2012; Gausserès 
et al., 1997; Mahé et al., 1994a).  Intrinsic and uniform labelling of dietary proteins with 15N (e.g., 
milk, soya protein isolate and wheat) have been used in particular to measure the metabolic 
fate of dietary nitrogen after its consumption so as to allow the investigation of postprandial N 
transfers into different metabolic pools with Ileal digesta, faeces, blood and urine being sampled 
in human subjects.  NPPU is calculated using true ileal digestibility and 15N-labelled protein 
utilization parameters (Tomé and Bos, 2000).  
In the NPPU method, human subjects are equipped with a blood catheter and a double-
lumen intestinal tube introduced through the nose up to the terminal ileum.  One lumen is used 
to perfuse a saline solution of phenol red as a non-absorbable marker of the fl ux of intestinal 
effl uents, and the other is used to aspirate ileal effl uent samples.  Basal blood, urine and ileal 
effl uent samples are collected.  After 60 minutes of basal ileal sample collection, the subjects 
receive a single 15N-labeled mixed meal (ingested 15N).  Then, during the 8 hours following meal 
ingestion, the ileal effl uents and urine are collected continuously on ice and pooled at 1-hour 
intervals and blood samples are collected every hour.  
Calculation of true ileal nitrogen and amino acid digestibility
Total nitrogen, dietary 15N nitrogen, total amino acids, 15amino acid (15AA) and phenol red 
concentrations are measured in intestinal effl uents.  The total nitrogen (Ntot) and amino acid 
(AAtot) fl ow rates are derived from nitrogen and amino acid concentrations and ileal fl ow rates:
Ntot = F x Ns/100 and AAtot = F x AAs /100
where F is the fl ow rate of ileal effl uents calculated from phenol red concentrations for each 
1-hour period, Ns is the nitrogen content of the ileal sample and AAs is the content of each amino 
acid in the ileal sample.  
The level of dietary nitrogen losses present in ileal samples (Ndiet) is determined from the 
dilution of the isotopic marker (15N) in the samples and similarly, the amount of dietary amino acid 
losses (AAdiet) recovered in ileal samples was calculated for each amino acid: 
Ndiet = Ntot x (APEs/APEm) and AAdiet = AAtot x (APEs/APEm) 
where Ntot is the amount of total N in the sample, APEs and APEm are the 15N enrichment excess 
(i.e. above the baseline value) of total nitrogen of the sample and the meal, respectively, AAtot 
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is the amount of individual amino acid (i.e. free amino acid peptides and protein-bound amino 
acids) in the sample and APEs and APEm are the 15N enrichment excess of the individual sample 
and the meal, respectively.
Endogenous nitrogen and amino acid contributions were derived from the differences 
between total and dietary nitrogen and amino acids, respectively.  Nitrogen and amino acid true 
digestibility (TD) in humans are calculated from the cumulated amounts of nitrogen and amino 
acids recovered at the ileal level and thus not absorbed in the small intestine, using the equation 
TD = (intake - ileal content) x 100/intake
where intake and ileal content are the cumulative amounts of nitrogen or amino acids ingested 
and recovered at the terminal ileum after 8 hours.
Calculation of NPPU 
Dietary 15N transferred to body urea (body 15N-urea) and transferred to urine, mainly as urea, 
(urinary 15N) are measured.  NPPU is calculated as follows: 
NPPU % = 100 x [ingested 15N – (ileal 15N + body 15N-urea + urinary 15N)]/ ingested 15N
Results for ileal digestibility and NPPU of protein sources
This NPPU method has been applied to a variety of different protein foods (Bos et al., 1999, 2003, 
2005, 2007; Gaudichon et al., 1995; Gausserès et al., 1997; Lacroix et al., 2006, 2008; Morens, 
2003; Mariotti et al., 1999, 2000, 2002;).  True ileal nitrogen digestibility measured for different 
protein sources were: milk protein, 95% (Bos et al., 2003; Gaudichon et al., 2002; Mahé et al., 
1994b); soya and pea protein, 91 % (Bos et al., 2003; Gaudichon et al., 2002; Gausserès et al., 
1997); wheat protein, 85-90% (Bos et al., 2005; Juillet et al., 2008); rapeseed protein, 84% (Bos 
et al., 2007).  In addition, True ileal digestibility values of dietary nitrogen and amino acids was 
also measured after the ingestion of milk or soya protein, with digestibility of amino acids ranging 
from 91% (glycine) to 99% (tyrosine) for milk protein, and from 89% (threonine) to 97% (tyrosine) 
for soya protein (Gaudichon et al., 2002).
An average value of 70 % can be considered as the NPPU of dietary proteins (Bos 
et al., 2005) when determined under optimized, controlled conditions in healthy adults. 
Comparison of the immediate post-prandial nitrogen utilization of different protein sources in 
adults adapted to an adequate level of protein intake shows values for post-prandial protein 
utilization ranging from 75-93% for high quality protein as milk protein to values of 63-66% for 
protein with lower quality such as wheat.  Specifi c NPPU values determined for milk, soya protein 
isolate and wheat were 81%, 78% and 66%, respectively (Bos et al., 1999; Bos et al., 2005; 
Mariotti et al., 1999; Tomé and Bos, 2000).  
In addition, the kinetics of dietary N appearance in ileal effl uent, plasma proteins, plasma free 
amino acids, body urea, urinary urea and urinary ammonia are calculated using a 13-compartment, 
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21 parameter model (Juillet et al., 2006).  The model calculations are fairly complex but allow 
one to predict the kinetics of dietary nitrogen in the body (Juillet et al., 2006).  Both the amino 
acid profi le of the protein and the kinetics of amino acid delivery to the blood can affect the 
postprandial splanchnic and peripheral uptake of amino acid in humans (Deglaire et al., 2009b; 
Fouillet et al., 2000, 2001, 2002b, 2003, 2009; Juillet et al., 2008).  Increasing protein intake 
increases splanchnic catabolic use while splanchnic catabolic use and peripheral anabolic use are 
inversely affected (Fouillet et al., 2009).  Interestingly, this approach shows a nutritional value of 
individual food proteins in the order animal protein (milk) > legume (soya, pea) protein > cereal 
protein (wheat).  
Critique of method and conclusions
This method represents a major advance in the evaluation of dietary protein quality.  The NPPU 
of Tomé et al. is very well developed in humans and with application to the pig model could very 
clearly be used to quantify the necessary correction or adjustment factors required to calculate 
human DIASS values from pig TID protocol studies.  In those instances where the existing and well-
described method in humans has been replicated in the pig, there has been excellent agreement 
of the values to the TID pig values (Deglaire et al., 2009a).  
Like other protocols discussed, this research method needs to be extended over a wider range 
of human foods, especially those with amino acid digestibility in the range of 50-80%.  This would 
create a viable bridge between the methods, as it will be possible to compare the results on the 
digestibility of the different proteins, including highly digestible and poorly digestible proteins, 
obtained by the different methods.  
A drawback of the method is that it relies on the use of 15N as a tracer and this stable isotope 
is currently expensive to produce.  In addition, it is restricted only to foods that can be intrinsically 
labelled with 15N.  Another drawback of the current NPPU method is it being unacceptably invasive 
for widespread use in humans due to the use of the naso-intestinal intubation technique to collect 
the ileal digesta.  Therefore, with the inclusion of this invasive procedure, this method is unlikely 
to be widely adopted for routine application.  However, the Working Group was apprised that the 
method could be simplifi ed and less-invasive and thus potentially more widely applicable.  While 
the development of this simpler and less invasive method is still in progress, the Working Group 
was encouraged by this potential enhancement as it appears to have great promise.  A signifi cant 
advantage of the method is that within one experiment data on both total nitrogen and individual 
amino acid digestibility of the food are produced.  
7.5 A DUAL TRACER APPROACH TO MEASURING DIAAS
Introduction
The measurement of the digestible indispensable amino acid score (DIAAS) (FAO, 2013) of 
proteins in humans is diffi cult because of the inaccessibility of the ileum.  A dual stable isotope 
tracer approach, which is being developed, promises to provide a minimally invasive means to 
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estimate digestibility, without the requirement for intubation or fi stulation of the gut.  The method 
also minimizes subject burden by requiring the consumption of only a single test meal from which 
the appearance of plasma amino acids is measured.  Furthermore, the method has the advantage 
in going beyond estimating the DIAAS, which largely describes the bioavailability of protein in 
foods or meals, to permitting the additional estimation of amino acid utilization, thus providing 
information on other aspects of protein quality.  
The dual tracer method utilizes intrinsic labeling to allow the study of the digestion of a specifi c 
plant protein independent of other proteins in the test meal and independent of endogenous 
proteins in the body.  However, appearance of amino acids in the accessible pool (blood) is not 
quantitative, due to uptake and metabolism of these amino acids in the splanchnic bed.  By 
accompanying the test protein with a small quantity of a highly digestible protein labeled with a 
different isotope, and ingested in the same balanced meal, the effect of the splanchnic removal 
can be corrected.  This principle presents a means to develop a non-invasive procedure that avoids 
intubation.  The novelty of this new approach is the use of this dual labeling where measurement 
of amino acid appearance from a test protein is compared with a reference protein.  The reference 
protein will be common to all measurements using this approach and originate from a commercial 
source of single-celled protein, highly enriched with a stable isotope.  It is important that the 
reference protein is highly digestible and culturally acceptable; microalgal protein of certifi ed 
quality meets this criterion.  Its amino acid composition need not be exactly the same as accepted 
high quality proteins like egg protein (or human milk protein), as correction terms can be applied. 
Intrinsic labeling
There is precedent for the intrinsic labeling of foods for human nutrition trials.  For carbohydrate 
assimilation studies, cereal and legume starch have been labeled with 13C (Edwards et al., 2002; 
Priebe et al., 2008; Verbeke et al., 2010).  For lipids and fat-soluble vitamins, 13C and 2H have 
been applied with equal success to label essential carbon skeletons (Bluck, 2009; Parker et al., 
1993; Tang et al., 2005).  For the intrinsic labeling of proteins, 15N has commonly been applied 
in microbial, plant and animal proteins (Gaudichon et al., 2002; Picou and Taylor-Roberts, 1969; 
Stack et al., 1989).  15N is unsuitable for tracing the carbon skeleton of individual indispensable 
amino acids, as transamination after digestion and absorption mixes the label through the alpha 
amino pool.  However, plants proteins can also be labelled with either 13C or 2H.
Two isotopic forms of each amino acid would be exploited in this dual labeling approach. 
Deuterium (2H) and 13C can be used to trace the indispensable amino acid carbon skeleton equally 
well.  However, tracer costs, together with the costs of intrinsic labeling of foodstuffs, argue that 
2H2O rather than 
13CO2 should be used to label the test protein.  Legumes are the protein sources 
currently under consideration, but developing intrinsically labeled proteins from other sources 
is feasible and possible.  A fi eld protocol is being developed to facilitate the effi cient labeling of 
growing legumes by the application one or more pulses of 2H2O in a predetermined pattern after 
fl owering.  
FAO Book 14-02-15.indb   22 2/14/2015   2:08:13 PM
23
Report of a FAO Expert Working Group
Test meals
Test meals comprising known quantities (about 20 g protein) of 2H-labelled grain legumes will 
be processed and prepared into meals according to local cooking practices.  Since the processing 
and preparation of food will impact the digestibility of protein, these variables will be carefully 
considered.  A commercial source of highly enriched 13C-enriched single cell protein (Spirulina; 
Arthrospira sp.) will be added at minimum quantity (20 mg protein) as the reference protein in 
each test meal.  
Protocol
Adult subjects will undertake a controlled study where, following a test meal, blood and breath 
samples will be obtained over a time course of no more than 8 hours (Figure 4).  Subjects will 
be asked to report to the nutrition facility after an overnight fast.  In addition to anthropometric 
measurements, they will be asked to give basal breath and blood samples.  Subjects will then 
consume a test meal containing 20 g of the 2H-labeled grain legume protein under test, in a 
balanced meal including unlabeled cereals, vegetables and condiments, along with 20 mg of 
a 13C-labelled reference protein and 1 mg of crystalline 13C6-phenylalanine, obtained from a 
commercial source.  Initially, for each labeled legume under study, blood and breath samples 
will be taken every 20 minutes for 4 hours and then hourly up to eight hours.  Blood sampling 
frequency and duration will be reduced in subsequent measurements after the pilot results have 
been appraised.  
Analyses
Free amino acids will be isolated from blood plasma by cation exchange following plasma protein 
removal.  Amino acids will also be prepared by acid hydrolysis from samples of each test and 
reference protein.  Volatile derivatives (ethoxycarbonyl ethyl amino acid esters) will be prepared 
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from amino acids prior to analysis of multiple-atom 13C enrichment by Gas Chromatography 
Mass Spectrometry (GC-MS) and of 2H-enrichment by GC-pyrolysis-Isotope Ratio MS (IRMS), 
(MacDonald et al., 2013).  A single H atom is lost from most IAA during transamination, but 
this process can be predicted (Commerford et al., 1983) and an equivalent post-digestive fate 
of test meal protein-derived IAA (labelled with 2H) and reference protein-IAA (labeled with 13C), 
can be assumed.  The combination of analytical instruments chosen allows the use of the same 
volatile derivative for both analyses while using minimal sample for 13C analysis with analysis of 
low-level 2H analysis by IRMS.  This strategy also permits analysis of different isotopologues by 
GC-MS so that a 1mg quantity of a crystalline amino acid with a unique signature (probably 13C6-
phenylalanine) can be added to the test meal to provide an absorption index.  
Outputs and calculations
A variety of indexes of protein quality will be derived: 
Digestibility: For each indispensable amino acid in the grain legume protein, digestibility will be 
calculated from the AUC of IAA from the test protein relative to IAA in the reference protein:
100 x (AUC 2H-IAA/AUC 13C-IAA) x [test meal 13C-IAA/test meal 2H-IAA] 
Absorption: AUC of the appearance of plasma 13C6-phe, normalized to tracer dose and body size, 
could be used as an index of absorption.
Validation studies 
A number of validation studies will be undertaken.  Firstly, if the test protein was the same protein 
as the reference protein but labeled with 2H, then tracer equivalence in terms of splanchnic 
handling can be confi rmed.  Secondly, the availability of highly digestible animal proteins will 
also be studied.  Feeding labeled grain legumes to a laying hen will produce eggs with protein 
labeled intrinsically with 2H-IAA.  A test meal based on intrinsically labeled egg protein will be 
used in a small number of subjects to demonstrate the protein quality outputs in an accepted 
highly digestible protein.  It is also proposed that test meals containing 2H-labelled milk protein 
will be assessed using this protocol.  Thirdly, validation studies on intubated adult volunteers will 
be carried out.  These invasive intubation studies will provide a bridge between bioavailability 
studies in the literature and the new non-invasive dual tracer method.  Finally, as the largest 
database of protein bioavailability exists in animals (rats, pigs) it is proposed that the dual tracer 
protocol be translated to a center experienced in undertaking ileal digestion studies in pigs, in 
order to compare digestibility estimates with both methods.  A typical protocol may involve a 
Latin square design where up to 6 test proteins were tested in 6 animals.  The test proteins would 
be labeled and include those with a variety of digestibility, including common grain legumes.  
Importantly, the studies described above will help to inform the design of a streamlined 
protocol suitable for use in larger studies and for use in children, with shorter duration and fewer 
blood samples.  This will be dependent on the co-incident appearance in blood of the two tracers 
in each protein source, as evidence that the proteins in the test meal were emptied from the 
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stomach and subjected to small intestinal digestion in the same time frame.  This will add strength 
to the proposed use of the appearance ratio of both tracers in individual IAA close to the time of 
maximal appearance.  If tracer appearance is co-incident, then the ratio of tracer enrichment at 
time of maximum appearance can be used as a proxy of their area under the curve (AUC) ratio 
using a single blood sample, as opposed to a series of samples taken over an 8-hour period.  
The dual tracer method for measuring DIAAS: larger studies and 
studies in children and infants
Larger studies and studies in children will benefi t from a streamlined protocol using as few blood 
samples as feasible.  Should it prove possible to prepare test meals so that tracers appear in 
coincidence, it is theoretically possible to derive parameters from a single blood sample taken 
close to the time of maximum tracer appearance.  Following the validation phase, the protocol will 
be evaluated to judge if a shorter protocol, ideally using a single blood sample, can be adopted 
for use in children.  For instance, Evenepoel and co-workers (2000) showed that a maximum of 
13C leucine appeared in blood occurred 2 hours after ingestion of a meal containing intrinsically 
labeled egg white protein.  
Strengths and limitation of the dual tracer approach to measuring 
DIAAS
The dual tracer approach addresses the requirement to measure the bioavailability of individual 
indispensable amino acids.  This approach is relatively non-invasive, requiring only blood sampling. 
The dual tracer approach has potential for use in children and infants, especially if tracers appear 
simultaneously and in co-incidence, facilitating use of a minimum number of blood samples. 
Studies will also be undertaken to determine if saliva or urine samples can be used to make these 
measurements more acceptable for use in infants.  Multiple output terms are feasible in addition 
to digestibility.  Additional parameters of protein quality, such as protein utilization (oxidation) 
can also be obtained if breath samples are collected in addition to blood samples.  It is potentially 
possible to interpret an AUC analysis of unlabeled amino acids to derive an index of dispensable 
amino acid turnover.  Finally, other measurements are accessible, such as analysis of the relative 
fractional synthetic rate of major plasma proteins.  
The principal limitation of the dual tracer approach is the cost of procuring stable isotope 
labeled proteins together with the cost of analysis.  Table 2 lists examples of the cost of 
representative tracers.  It should be noted that these costs do not account for ineffi ciencies during 
intrinsic labeling of plants, which can be considerable.  The cost of tracer procurement will be 
mitigated by use of state-of-the-art Mass Spectrometry (MS) so that minimal quantities of tracers 
can be used.  It is not proposed to apply the method in very large groups, but in key groups with 
the intention in informing larger nutrition trials.  Further, it should be noted that by minimizing 
the number of samples required to derive the necessary outputs, a single MS facility could support 
studies over a wide geographical area.
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The need for extensive validation is another limitation.  As a novel concept, validation studies 
are necessary for the approach to become widely accepted, but these can be accomplished under 
controlled conditions and in a small group of healthy adult volunteers.  A fi nal limitation is the 
assumption that in the dual tracer design, splanchnic removal is the same for amino acids derived 
from the test protein and reference protein.  
Table 2: Example of current tracer costs (source: Cambridge Isotope Laboratories Inc., MA, USA, 
March 2014)
Plant Labeling Feedstock Test meal tracers
Material Cost Material Cost Cost /‘dose’
2H2O $0.50 /g Spirulina, whole cells $475 /g $16.5 /‘dose’
13CO2 $56.8 /g
13C6-phenylalanine $780 /0.25g $3 /‘dose’
(15NH4)2SO4 $48.0 /g
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Section 8:
Final considerations of the working group
Following the deliberations on research protocols and methods, the Working Group summarized 
their general recommendations and considerations for future work:
• The experts concluded that conceptually true ileal amino acid digestibility as expressed 
by DIAAS was preferable to the faecal crude protein digestibility as expressed by PDCAAS 
as the accepted protein and amino acid quality evaluation method.  However, they also 
recognized that the complete value of DIAAS could not be realized until there are suffi cient 
accumulated digestibility data for human foods as determined by competent national and/
or international authorities.  A meeting of experts and stakeholders may be required to 
assess the size and quality of the dataset and determine the timeline for full adoption and 
implementation of DIAAS.  
• To allow an informed decision regarding DIAAS, there is the need to develop a fully 
accessible, robust database on amino acid digestibility of foods and diets from different 
regions of the world.  In addition, there is a need to identify commonly consumed human 
foods focusing on the diets consumed by vulnerable populations of varying ages in low 
income countries with the need to conduct multiple studies using the same methodologies 
in different regions of the world.
• Before a fi nal decision is made concerning the adoption of DIAAS, there will be a need 
to review the practical effects for public health policies and programmes in using true 
ileal amino acid digestibility (via DIAAS) instead of faecal crude protein digestibility (via 
PDCAAS).  Preliminary work concerning the public health policies and programmes could 
be initiated in the near future.
• There is need for protocols to assess protein requirements in vulnerable groups with 
increased requirements due to physiological changes such as pregnancy, chronic 
infl ammation and the effect of sanitation and hygiene.  In addition, reference patterns 
for these vulnerable groups will need to be developed and applied to the amino acid 
requirements that will be used with the new DIAAS data.  
• In discussing practical steps forward, there is the need to identify funds for research. 
The experts believed that public and private sector funding would be required to carry 
out this work and efforts should be made to encourage such funding.  It would be most 
advantageous that there be coordination of the funding of the research and data collection. 
• There is a need to foster collaboration with international and national agriculture research 
institutions for introducing stable isotopes into various plants.  This would require training 
and funding for equipment to assist institutions.  In addition, to ensure sustainability and 
relevance, the experts suggested that it would be advantageous for young researchers 
from developing countries to be given opportunities to participate in research on this topic. 
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• A long term recommendation is that there is a need to develop a method that can be used 
by government agencies to regulate specifi c foods in terms of protein quality.
• In addition, the potential for the additivity of DIAAS measurements in mixed meals and 
prepared food products that contain multiple ingredients must be assessed.
• There is a need to clarify the nomenclature related to digestibility (e.g. apparent, true, 
standardised).
FAO Book 14-02-15.indb   28 2/14/2015   2:08:14 PM
29
Report of a FAO Expert Working Group
Annex 1:
True ileal amino acid digestibility assay: a 
standard methodology
The 2011 FAO Expert Consultation on protein quality in human nutrition recommended the 
following:
“It is recommended that the FAO convene a Working Group, as a matter of urgency, to agree 
upon an experimental protocol to enable the development of a more robust data set of the 
true ileal amino acid digestibility of human foods and agree upon a method for assessment of 
the potential impact of the use of true ileal amino acid digestibility data.  The protocol should 
include recommended best practice for a pig-based assay for true ileal amino acid digestibility 
determination” (FAO, 2013).
The following protocols address this recommendation.
Human-based assay for true (corrected for basal endogenous amino 
acid losses) ileal amino acid digestibility
Background: The 2011 Expert Consultation stated that “digestibility should be based on the true 
ileal digestibility (i.e. determined at the end of the small intestine) of each amino acid preferably 
determined in humans .....” (FAO, 2013).  When liquid or non-fi brous, powdered type foods 
(e.g., casein, gelatin, zein) are to be assessed, the naso/ileal intubation method as described by 
Gaudichon et al. (2002) is preferred.  Where fi brous, coarse foods (e.g. cooked beans) are to be 
assessed whereby representative digesta sampling and tube blockages may be a problem, the 
protocol described by Moughan et al. (2008) involving adult ileostomates should be followed, 
with the protein source included in the subject’s general diet for 7 days before digesta collection. 
Endogenous losses can be determined according to the method as described by Rowan et al. 
(1994) where the subject is its own control.
Pig-based assay for true (corrected for basal endogenous amino acid 
losses) ileal amino acid digestibility
Background: Determining true ileal amino acid digestibility in humans is diffi cult and expensive. 
Consequently, for the routine evaluation of foods, it is necessary to adopt an animal model.  The 
Expert Consultation (FAO, 2013) recommended the pig as the best model for the adult human and 
where this model cannot be applied, the growing rat.  True ileal amino acid (including reactive 
lysine) digestibility is the preferred method in pigs for predicting dietary amino acid uptake.  The 
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ileal assay has been thoroughly validated for its application in the pig and is now used routinely 
to assess the protein quality of feedstuffs for pigs and for other simple-stomached farm animals. 
Research by Deglaire et al. (2009a) and Rowan et al. (1994) and has shown a high degree of 
agreement for true ileal amino acid digestibility between the adult human and the growing pig, 
but this is based on a limited number of foods.  In light of this, the 2011 FAO Expert Consultation 
recommended that more work be conducted to compare true ileal amino acid digestibility values 
between the human and growing pig using protein sources that are representative of those 
consumed by human populations, to further validate the pig as a model animal.  In addition, if 
a world database on the true ileal digestibility of human foods is to be generated, a standard 
protocol would be of considerable benefi t.  The following describes a standard protocol, developed 
by a number of scientists with expertise in the fi eld.  
Protocol
Approval from an appropriate animal ethics committee must be obtained and animals must be 
housed and cared for in accordance with the requirements of the organisation where the studies 
are conducted.
Animals:
30-100 kg commercial-type pigs
T-cannula (placed proximal to the ileo-caecal valve) 
Minimum of 5 animals per test protein source
Minimum 5-day recovery from surgery
Feeding protocol:
Animals adapted to an appropriate human-type diet
Feed at 8% of body weight0.75/d as 2 meals at ≥9 h interval between meals
All nutrient requirements, except protein/amino acids, to meet those prescribed by the NRC 
(2012) 
Minimum of 5 days adaptation to the diet and environment
Water ad libitum
Test diet composition1,2:
Test protein source included at a CP3 concentration of 100 g/kg diet DM 
Mixture of purifi ed sucrose, corn oil and cellulose (micro-crystalline) in a ratio of 10:5:3 (180 
g/kg DM)
1 In order to maintain a dietary CP concentration of 100 g/kg, for low protein foods where CP is <150 g/kg DM, the test 
ingredient can be diluted with a mixture of cellulose and corn oil (1:1).  For foods where the CP concentration is <10 g/
kg DM CP, the test diet should consist of the test ingredient, vitamin/mineral mixture and TiO2.
2 The composition of diets for comparing true ileal amino acid digestibility in pigs and to humans may differ from that 
shown above.
3 Crude protein (CP) is estimated based on the determined N content of the protein source and using an N to protein 
conversion factor of 6.25.
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TiO2 (3 g/kg DM)
Vitamin/mineral premix at prescribed inclusion rate
The diets are made up to their total weight with purifi ed corn starch
Test protein source should be:
a. fed in a similar form as consumed by humans (appropriately ground if required)
b. homogeneously distributed through the rest of the diet
Housing conditions:
Individually housed in pens without bedding materials able to be consumed in such a manner 
as to ensure that coprophagy does not occur
Thermoneutral zone 
12 hour light/dark cycle
Digesta collection:
Collected over two periods of ≥9 hours, starting directly after a meal and separated by at least 
2 meals
Collection bag to contain antimicrobial compounds 
Collected digesta frozen as soon as possible
Digesta collected to be bulked over days and hours of collection per animal
Endogenous losses determination:
Feeding a protein-free diet 
Each animal is its own control
Feeding at 8% of body weight0.75/d fed as 2 meals at ≥9 h interval between meals
Chemical analyses of diet and digesta:
TiO2, amino acids4, dry matter
Rat based assay for true (corrected for basal endogenous amino acid 
losses) ileal amino acid digestibility
Background: The Expert Consultation stated that “digestibility should be based on the true 
ileal digestibility (i.e. determined at the end of the small intestine) of each amino acid preferably 
determined in humans ....., but if this is not possible, in the growing pig ....., or in the growing rat, 
in that order (FAO, 2013).  The following describes a standard protocol developed by a number of 
scientists with expertise in the fi eld.
Protocol
Approval from an appropriate animal ethics committee must be obtained and animals must be 
housed and cared for in accordance with the requirement of the organisation where the studies 
are conducted.
4 Amino acid analyses should be conducted according to the standard protocol as described by Rutherfurd and Gilani 
(2009).
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Animals:
200 - 250 g male laboratory (e.g. Sprague-Dawley) rats
Minimum of 5 animals per test protein source
Feeding protocol:
Animals adapted to environment, diet and feeding regimen and fed an appropriate human-
type diet for 9 days 
Nine hourly feeds from 8.30-16.30 with feed freely available for 10 min each hour 
All nutrient requirements, except protein/amino acids, to meet those prescribed by the NRC 
(1995) 
Minimum of 5 days adaptation to the test diet and environment
Water ad libitum
Test diet composition5:
Test protein source included at a level of 100 g/kg CP6 (% DM of the diet)
Mixture of purifi ed sucrose, corn oil and cellulose (micro-crystalline) in a ratio of 10:5:3 (180 
g/kg DM)
TiO2 (3 g/kg DM)
Vitamin/mineral premix 
The diets are then made up to their total weight with purifi ed corn starch.
Test protein source should be fi nely ground and homogeneously distributed in the diet such 
that selective consumption of dietary components is not possible
Housing conditions:
Individually in wire-bottom cages to prevent coprophagy
Thermoneutral zone 
12h light/dark cycle
Digesta collection:
Asphyxiation with CO2 and decapitation or cervical dislocation
Dissection of the ileum section 20 cm anterior to ileal-caecal valve
Flushing of digesta using distilled deionised water
Collected digesta for each animal frozen as soon as possible 
Stomach content checked for coprophagy
5 In order to maintain a dietary CP concentration of 100 g/kg for low protein foods where CP is <150 g/kg 
DM, the test ingredient can be diluted with a mixture of cellulose and corn oil (1:0.6).  For foods where the 
CP concentration is <10 g/kg DM CP, the test diet should consist of the test ingredient, vitamin/mineral mixture and 
TiO2.
6 Crude protein (CP) is estimated based on the determined N content of the protein source and using an N to protein 
conversion factor of 6.25.
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Endogenous losses determination:
Feeding a protein-free diet 
As with the rats fed the test diet, use the same housing and procedures.
Chemical analyses of diet and digesta:
Ti, amino acids7, dry matter
7 Amino acid analyses should be conducted according to the standard protocol as described by Rutherfurd and Gilani 
(2009).
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Annex 2:
Detailed Protocol of the Indicator Amino 
Acid Oxidation (IAAO)
IAAO Methodology - Pigs:
The details of the protocol for pigs have been described in the experiments published by Levesque 
et al. (2010) and Moehn et al. (2007).  The details of the protocol for humans have been described 
by Prolla et al. (2013).  Additional comments and clarifi cations are provided below.  
Reference diet 
The basal diet should consist of highly digestible ingredient such as whey or casein to meet 
approximately 30% of the dietary requirement of the test amino acid.  The same highly digestible 
protein must be used as the reference protein in the basal diet that will be used in the pig TID 
and human IAAO experiments for bioavailability, and comparability between the pig TID and the 
human experiments is required to calculate human DIAAS from the extended pig TID database.  
The remaining amino acids should be supplemented as free amino acids.  During the adaptation 
period to the test food, this will be in the pattern of the test food up to at least 120 % of the 
requirement of the pig (NRC, 2012) according to the rate of food intake.  During the experimental 
period, when oxidation is being conducted, all of the free test amino acid must be removed from 
the diet and replaced, either with increments of the test amino acid to create the reference slope, 
or with increments of the test foods.  All other amino acids must be provided in the diet to provide 
at least 120% of requirement (see Sub-section 7.2).  
First limiting Amino Acid
The test AA must be fi rst limiting in the diet to ensure that the intake of the test AA drives the 
change in indicator oxidation.  This is achieved by providing all other amino acids, in the same 
pattern as the test protein, at approximately 120% of dietary EAR.  This is approximately 2 SD 
above the mean requirement and thus can be assumed to exceed the demands of the majority 
of the population.  Intakes higher than 120% may be chosen if there is uncertainty about the 
requirements for the amino acids or their availability in the test protein is expected to be very low 
or is unknown.
Linearity of oxidation response
The change in indicator oxidation to incremental changes in test AA must be linear to allow 
calculation of availability.  This is accomplished by restricting the maximum intake of the test 
amino acid to no more than 60 to 80% of the EAR.  This intake is necessary because intake must 
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be at least 2 SD below the requirement to ensure that none of the subjects in the population 
sample will be meeting their demand for the limiting amino acid.  If an individual’s intake were to 
exceed the requirement, the slope would not be linear because oxidation of the indicator amino 
acid would be in the plateau phase.  Linear regression is used to determine the slope of the best-
fi t line.
Tests for linearity must always be conducted for the test amino acid.  The researcher has a 
choice of measuring linearity of response to the test food.  If the food is within the reference 
range of foods used to develop the correction factors for pig TID then this may not be necessary 
and only the intake containing 60-80% of the EAR will be required.  However, if the test food is 
potentially outside of the reference range of foods used to develop corrections or adjustments to 
the pig TID database then it is recommended that linearity of response be conducted for the test 
food also.  
Lack of interactions
The observed response must not be infl uenced by dietary nutrients other than the foodstuff being 
tested (Batterham, 1992; Littell et al., 1995).  Of course, if the goal of the experiment is to test 
interactions between foods or to study the infl uence of anti-nutrients, then these criteria can be 
waived after properly characterizing bioavailability of amino acids in the test foodstuff.
Adaptation period
The minimum adaptation period for pig IAAO bioavailability should be the same as the adaptation 
period used in the pig TID experiments (see Annex 1) to ensure comparability of experiments and 
transferability to the pig TID database.  If the test food is highly fi brous, is suspected to be very 
poorly digested or contains anti-nutrients that require longer adaptation, then information on the 
minimum adaptation period should be obtained from the literature or the oxidation experiment 
can be repeated at intervals to determine the adaptation period.  
Isotopic steady state
An isotopic steady state in oxidation of the indicator amino acid must be achieved during each 
individual test of oxidation.  The percent (%) of the dose oxidized per unit time must only be 
calculated after the oxidation reaches a plateau otherwise the measurement will be unduly 
infl uenced by the rate of absorption and transport of all the amino acids rather than bioavailability 
of the test AA.
Subjects as own control
Each subject must be used as their own control in a repeated measurements design.  Each study 
subject receives each of the series of 3 or 4 reference diets supplying free test AA (crystalline 
form) at incremental increases to a maximum of 80% of the EAR, as described above.  Each 
subject also receives each of the test diets containing the protein-bound AA.  The use of repeated 
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measurements within the same subject reduces the effect of individual variability, and increases 
the sensitivity of the estimate by accounting for between-subject variation, which is recognized 
as at least 20 % in humans (WHO, 2007) and can be up to 30% (Zello et al., 1993).
Conditions for the indicator Amino Acid 
There are a number of conditions regarding intake of the indicator amino acid that are critical for 
the successful application to assessment of protein quality and amino acid bioavailability by the 
IAAO method.  
The indicator amino acid increases in excess as against its dietary requirement for protein 
synthesis, as intake of the test protein or amino acid decreases.  To ensure the constant intake of 
indicator amino acid, on a bioavailable basis, requires knowledge of both the concentration of the 
indicator in the test foods and of its bioavailability.  
Concentration of the indicator amino acid may be determined by direct amino acid analyses 
or nutrient composition tables.  Bioavailability in humans will not be known unless it has been 
measured, which is rare.  The Expert Consultation (FAO, 2013) and the Working Group concluded 
that TID amino acid values from the pig were highly correlated to the few measured values in 
humans.  Therefore, bioavailability values for the indicator amino acid in the test protein may be 
taken from published TID values in the pig or the values predicted for humans from the pig data, 
when these become available.  If these are not available for the test protein, then the preferred 
approach will be to measure pig TID of the indicator amino acid prior to the IAAO experiments. 
If this is not possible then an estimate may be made, with the proviso that the experiment may 
need to be repeated if a plateau response is observed at either lower or upper intakes of the test 
protein (See below), indicating that the estimated bioavailability value or the indicator amino acid 
was either too low or too high.  
In addition to being constant, intake of the indicator amino acid, on a bioavailable basis, 
must not become either defi cient or excessive (see Figure 5).  The indicator amino acid increases 
in excess as against its dietary requirement for protein synthesis, as intake of the test protein or 
amino acid decreases.  If intake of the indicator amino acid is in too great of an excess (zone 1 
Figure 5), then the slope of the line at the lower intakes of the test protein or amino acid may 
plateau because at some point the intake may exceed the oxidative capacity of the body for the 
indicator amino acid.  If the line is at plateau, it will no longer be in linear and decreasing slope 
(zone 2 Figure 5), and therefore the slope ratio analyses will be incorrect.  Alternatively, if intake 
of the indicator amino acid were to be defi cient (below dietary requirement on a bioavailable 
basis) then at upper levels of intake of the test protein or amino acid, the slope of the line will 
also plateau (zone 3 Figure 5) because protein synthesis will be limited by intake of the indicator 
amino acid, rather than intake of the test protein or amino acid.  Again, the slope ratio analyses 
will be incorrect.  The response shown in zone 3 will also occur if the intake of the test protein 
or amino acid exceeds its dietary requirement, which is what happens during IAAO requirement 
experiments.  To ensure intake of the indicator amino acid is neither defi cient nor excessive the 
dietary requirement of the test population must be known.  For information on requirements, 
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the reader is referred to the many publications on amino acid requirements (e.g. WHO, 2007), 
particularly those that used amino acid oxidation; because if those experiments used diets based 
on free amino acids, the requirements represent the bioavailable amino acid requirement.  
Figure 5: Response will be non-linear if the intake of the indicator 
                 amino acid is either in excess (Zone 1) or deﬁcient (Zone 3)  
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IAAO Methodology - Humans: 
The IAAO method to measure metabolic availability has been described by Prolla et al., 2013.  The 
following is a brief description and explanation of key issues and differences between the method 
of Prolla et al., 2013 and the protocol recommended in the current report.  
Isotope protocol
Test diets must have the appropriate amounts of phenylalanine + tyrosine, to ensure sensitive 
partitioning of response between protein synthesis or oxidation.  The amount of L-[1-13C]
phenylalanine given during the study day must be subtracted from the dietary provision of 
phenylalanine such that the total intake of phenylalanine is 30 mg/kg/d with a tyrosine intake of 
40 mg/kg/d (to ensure an excess of tyrosine).  Previous human studies have used priming doses 
of NaH13CO3 (2.07 µmol/kg) and L-[1-
13C] phenylalanine (99 atom % excess, 40 µmol/kg).  The 
continuous dose of L-[1-13C] phenylalanine will be 15 µmol/kg/h, given hourly until the 9th meal 
(see Figure 6).  If other isotopic choices are made, then additional studies need to be conducted, 
especially linearity of response to both the test amino acid and protein bound amino acid, to 
ensure adequate responses in indicator amino acid oxidation to measure amino acid availability. 
Dietary composition
Diets should be designed to provide a protein intake of 1.0 g/kg/d.  Diets should achieve an energy 
intake of 1.5 X Resting Metabolic Rate with approximately 52%, 36% and 12% of energy from 
carbohydrates, fat and protein, respectively.  For the duration of all experiments, subjects should 
consume a daily multivitamin supplement and 500mg of choline to ensure adequate vitamin 
intake.
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The study day diet should be consumed as 9 isonitrogenous and isocaloric hourly meals, each 
meal representing one twelfth of the subject’s total daily protein and energy requirement.  Each 
study day will be 10 hours long (see Figure 6).
Test for linearity of free Amino Acid intakes
The fi rst objective should be to ensure that metabolic availability is being measured during 
a predictable response to graded intakes of test amino acids in each individual subject.  For 
example, recommended intakes to test for linearity of response to lysine could be in the range of: 
10, 15, 20, 25 and 28 mg Lysine/kg/d which would meet 28.5, 43, 57, 71 and 80 %, respectively 
of the mean lysine requirement in adult men.  
Basal and test protein diets
The basal diet should consist of highly digestible protein that attains a maximum of 30% of the 
dietary requirement of the test amino acid.  As described in the pig IAAO protocol (see above) use 
of the same reference diet in both humans and pigs will allow comparisons across all experiments 
and species.  The remaining amino acids should be supplemented as free amino acids.  During 
the adaptation period to the test food, free amino acids will be provided in the pattern of the 
test food to a minimum of 120% of the requirement of the human EAR (WHO, 2007) for the most 
limiting amino acid.  During the experimental period, when oxidation is being conducted, all of 
the free test amino acid must be removed from the diet and replaced, either with increments of 
the test amino acid to create the reference slope, or with increments of the test foods.  All other 
amino acids must be provided in the diet to provide a minimum of 120% of mean requirement of 
the most limiting amino acid.  
A highly digestible ingredient must be used as the reference protein and foundation of 
the basal diet.  Whey is recommended because it has a relatively low phenylalanine content 
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and therefore a wide range of foods with high phenylalanine concentrations can be studied. 
Bioavailability of amino acids in milk proteins has been tested in humans (Bos et al., 1999) and 
may be adopted for use in the model.  
The test protein should be included in the diet to provide a maximum of 40% of the total test 
amino acid because approximately 40% will be provided by EHC in basal diet and the remainder 
as free amino acid.  With this protocol, diets with amino acid bioavailability as low as 60% can be 
tested.  The experimental subjects may not be able to consume 40% of their protein requirement 
from the test protein for several reasons.  For example, they may not be physically able or willing 
to consume that quantity of the test protein; this may occur if either the protein concentration or 
the amino acid bioavailability is low.  Alternatively, there may be anti-nutrients in the food which 
restrict its intake.  Intake may need to be adjusted accordingly.  
If the protein concentration of the food is low (e.g. <12%) or its expected amino acid 
bioavailability is less than 60%, then two approaches are possible; either the intake from free 
amino acids must be more than 120%, or the inclusion of the test protein must provide less 
than 40% of the total; otherwise the subjects will have a defi cient intake of the test amino 
acid.  Humans have the ability to oxidize large quantities of excess amino acids (Elango 
et al., 2012b) therefore intake of any amino acids in excess of 120% is not considered to be an 
issue and therefore this approach is acceptable.  Alternatively, inclusion of the test protein can be 
reduced to less than 40%, and the free amino acids supplemented to 120% or greater to ensure 
that the intake is adequate for even the least bioavailable amino acid.  
Adaptation in response to test protein
Further research in the human protocol may be required to establish length of adaptation time 
for less digestible intact proteins.  The adaptation times should be published and made available 
as soon as the research is complete.  The minimum adaptation should be initially based on the pig 
TID protocol, i.e. 5 days.  This period may vary with the test proteins, as more fi brous foods may 
require additional length of time to adapt and adaptation may need to be established for some 
specifi c foods.  In addition, the Working Group considered that there may be situations and foods 
for which it may be valuable to study both adapted and non-adapted conditions.  
Effect of cooking/heat processing 
Cooking of human diets may result in chemical complexes or loss of amino acids, which makes 
them unavailable for protein synthesis (e.g. Prolla et al., 2013).  Wherever possible, the test food 
must be prepared with the typical cooking method.  If a variety of cooking methods are used 
for a specifi c test food then these should also be tested for the effect on individual amino acid 
availability.  In addition, some foods are always cooked and prepared in mixtures and are not 
consumed separately, therefore, it is advisable that the food be tested separately, if at all possible, 
so that it can be used on an additive basis, but also tested in the mixture as cooked. 
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Annex 3:
The PPU Protocol
The experimental protocol is shown in Figure 7.  The 13C-1 leucine infusion lasts 9 hours and starts 
after an overnight fast.  The single meal is given after 3 hours and the infusion is continued for a 
further 6 hours.  Sampling times are shown in Figure 7 within each period for blood, breath, and 
carbon dioxide production.  It is discussed in detail in Millward et al. (2002).
0
Time
(min) 60 120 180 240 300 360 420 480 540
Leucine
infusion
Meal
Blood
Breath
CO2??????????
Figure 7: Experimental protocol
Experimental design factors
Subjects
The principle of the PPU measurement is that protein utilisation is measured during consumption 
of a meal representing 50% of the subject’s usual daily intake.  This means that the protein intake 
is not in excess of the capacity for net protein deposition which might limit utilisation.  Whilst it is 
not necessary to exactly match the intake to individual habitual intakes it is important to ensure 
the meal will reasonably meet 50% of the subject population group’s habitual intakes.  If this is 
not known then intakes should be assessed by a 4 day food diary prior to the study.  Before the 
studies begin, no restrictions on activities of daily living are needed although subjects should be 
encouraged to regulate their eating patterns to a diurnal cycle of 12 hour of feeding and 12 hour 
of fasting beginning at the expected time of the meal during the study day.  It is also important 
that the baseline leucine oxidation rate, measured between 120 and 180 minutes of the infusion, 
is a true post-absorptive measurement after an overnight fast with the last meal 10 hours before 
the start of the infusion.
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Meal composition
Test Meal: The composition of the meal should refl ect the objective of the study: i.e. evaluation 
of a single source protein or of protein from a mixed meal.  For a single source protein it is 
best that the P:E ratio and the carbohydrate-fat ratio are standardised although there may be 
constraints given the need to formulate a palatable meal which can be consumed within a 
short period of time (e.g.10-15 minutes).  As examples, in a published study of wheat and milk 
utilisation (Millward et al., 2002) the meals were designed to provide the protein at a relatively 
high protein-energy value: i.e. 0.5 g protein/kg and 30 kJ/kg, i.e. a protein-energy ratio of 30% 
and the fat content of the meal was kept as low as possible to maximize gastric emptying.  Thus 
the milk-protein meal consisted of fresh skim milk and dissolved potato dextrose with low natural 
13C enrichment giving protein-carbohydrate-fat ratios of 32.3:65.7:2.0.  The wheat-protein meal 
consisted of wheat gluten, plain fl our, and low naturally 13C-enriched potato dextrose.  Wheat 
gluten was used to provide a high protein content in a small volume.  It was fed as a dry-fried 
pancake made from dough prepared from an equal weight of gluten and plain fl our with water 
and was served hot, accompanied by a drink containing dissolved potato starch with a small 
amount of sugar-free orange beverage.  In this case the protein-carbohydrate-fat ratios were 
36.7: 72.3: 1.0. 
For mixed meals especially those based on plant protein sources it would be diffi cult to achieve 
0.5g protein/kg from a single meal which could be consumed over a short time period because 
this would represent a major fraction of the daily intake.  Thus for diets based on legumes and 
cereals, overall P:E ratios range from 9-11% (Millward & Jackson, 2004) so that at energy intakes 
of say 1.4 X BMR during the infusion, for a 70 kg adult this diet provides about 0.75g protein/kg/d 
and 126kJ/kg per day.  Thus providing 30kJ/kg (25% of the day’s intake) would provide only about 
0.2g/kg/d.  If the protein intake is too low then the error in measuring the AUC for the increase 
in leucine oxidation becomes large.  A single meal based on 40% of the daily intake (50kJ/kg) 
would provide 0.3g protein/kg which is probably suffi cient protein.  Clearly it would be necessary 
to conduct meal size studies to assess the accuracy and practicality of the assay.
Free amino acid meal control: This meal serves to assess the biological value (free amino 
acid pattern relative to that of the metabolic demand) of the test meal.  It must be formulated 
therefore with the same amino acid pattern and content as the test meal and with the same 
overall energy content.  
Choice and quantity of tracer 
In this assay where the actual rate of tracer oxidation is used in the calculation, the tracer 
oxidation rate must be measured as accurately as possible.  This requires a measureable precursor 
in blood of the excreted 13CO2.  Thus 
13C-1 leucine is suitable since the 13C enrichment of the 
transamination product of leucine, α-ketoisocaproate is easily measurable by standard GC-MS 
techniques.  An infusion rate of 0.5mg/kg/h of L-[1-13C] leucine (99% 13C), has been shown to be 
suffi cient with a priming dose of 0.5mg/kg.  The bicarbonate pool is also primed with 0.2 mg/kg 
of NaH13CO2.
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Annex 4:
FAO Working Group Meeting on 
Developing Protein Quality Evaluation 
Research Protocols 2-5 March
St John’s Research Institute
Background
FAO convened an Expert Consultation on dietary protein quality evaluation in human nutrition 
in Auckland, New Zealand from 31 March to 2 April 2011.  A primary objective was to assess 
the existing Protein Digestibility Corrected Amino Acid Score (PDCAAS) method for expressing 
protein quality and to examine the suitability and advisability of replacing it with the new 
measure “Digestible Indispensable Amino Acid Score” (DIAAS).  Although the Expert Consultation 
recognized that the DIAAS was conceptually superior to the PDCAAS, it acknowledged that there 
was a need for more data, particularly related to humans.  The Expert Consultation called upon FAO 
to organize a working group to develop research protocols that would allow the measurement 
of true ileal digestibility values across different animal models (pig, rat) and human studies using 
protein sources that are representative of those consumed by human populations.  
Objective of the meeting
The objective of the 4-day working group meeting is to develop specifi c and viable research 
protocols related to assessing protein quality in human foods.  
Expected outcomes
Immediate outputs:
The expected outcomes and outputs of the working group meeting are:
1) A short report describing the working group’s deliberations and conclusions;
2) Specifi c and viable research protocols that can subsequently be submitted for funding;
3) Communication note reporting on the working group recommendations submitted for 
publication in one or more journals to notify the research community about the protocols.
Long term output:
Following the anticipated accumulation of data and information resulting from the research 
carried out, FAO would sponsor an expert meeting on protein quality and the implications for 
human nutrition.  
Annex 4
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Provisional Agenda
SUNDAY 2 March
08:15 Pick up at Hotel
08:30 – 09:00 Registration 
• Receive DSA
• Wi-Fi access
Bangalore Meet 
Secretariat
09:00 – 10:30 - Administrative announcements & Welcome
- Welcome 
- Overview of process
- Self-introduction of participants with brief description 
of their work related to objectives of the meeting
- Comments on the agenda & meeting facilitation
- Brief explanation of FAO’s interest and activity in 
protein requirements and quality assessment
A. Kurpad
W. T. K. Lee
J. Albert 
All participants 
J. Albert
R. Weisell
10:30 - 11:00 Coffee break
Session 1: Rationale for the Working Group - Facilitator: R. Ball 
11:00- 12:00 Brief review of 2011 Expert Consultation and salient 
points for the working group objectives
P. Moughan and R. Uauy 
(Chair & Vice-Chair of 
2011 consultation)
12:00 – 12:30 Discussion
12:30 – 13:30 Lunch
Session 2: Context of protein quality evaluation – Facilitator: A. Kurpad
13:30 – 14:00 Protein quality – implications for public health 
recommendations and Discussion
R. Uauy
14:00 – 14:30 A perspective on methods for determining protein quality 
and discussion
J. Millward
14:30 – 14:45 Coffee Break
14:45 – 17:00 Discussion and identifi cation of research gaps All participants
Evening is free
MONDAY 3 March
Session 3: Methods for measuring protein digestibility in human foods - Facilitator: D. Tomé 
08:30 Pickup at the hotel
09:00 – 10:00 Current available data W. Hendriks / 
P. Moughan 
10:00 – 10:30 Discussion
10:30 – 11:00 Coffee Break
11:00 – 12:00 Determination of metabolic availability of protein bound 
amino acids using the “Indicator Amino Acid Oxidation 
Technique” 
R. Ball / R. Elango
12:00 – 12:30 Discussion
12:30 – 13:30 Lunch
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Session 4: Protein digestibility - continued. - Facilitator: R. Uauy
13:30 – 14:30 Determination of metabolic availability of protein bound 
amino acids using stable isotope labelled protein
D. Tomé
14:30 – 15:00 Discussion
15:00 – 15:15 Coffee Break
15:15 - 16:15 Protein Quality: the promise of intrinsic labels with amino 
acid-specifi c analysis
T. Preston/ A. Kurpad
16:15 – 16:45 Discussion
18:00 Pick up at Hotel for Dinner
19:00 Dinner in a local restaurant 
TUESDAY 4 March
Session 5 Limitations of current methods – animal and human - Facilitator: J Millward 
08:30 Pickup at the hotel
09:00 – 10:30 Round table presentation and discussion – Limitations of 
animal models
W. Hendriks/
P. Moughan/R. Ball
10:30 – 11:00 Coffee Break
11:00 – 12:30 Round table presentation and discussion – Limitations of 
current methods in human
D. Tomé/A. Kurpad/
R. Elango
12:30 – 13:30 Lunch
13:30 – 14:15 Tour of the St. John’s facility Kurpad
Session 6: The way forward - Facilitator: T. Preston
14:15 – 15:45 Technical discussion and preparation of protocols
 Assignment of protocol drafting groups
All 
15:45 – 16:00 Coffee Break
16:00 – 18:00 Preparation of protocols Drafting groups
WEDNESDAY 5 March
Session 7 Approval of the report  Facilitators: R. Weisell and J. Albert
08:30 Pickup at the hotel
09:00 – 12:30 Presentation of protocols and funding opportunities Drafting groups assign a 
presenter
10:30 – 11:00 Coffee Break
11:00 – 12:30 Discussion continues
12:30 – 13:30 Lunch
13:30 – 15:00 Review of the draft report 
Preparation of communication for publication
All
To be determined
15:00 – 15:15 Coffee break
15:15 – 16:00 Approval of the report and annexes All
16:00 – 16:15 Closing T. Raj and W. T. K. Lee
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Annex 5:
List of Participants at the FAO Working 
Group on Protein Quality
Annex 5
Experts 
1. Dr. Ronald O. Ball
Professor Emeritus of Nutrition
Dept of Agricultural, 
Food and Nutrition Sciences,
Rm 4-10 Agriculture and Forestry Centre
116 St and 85 Ave 
University of Alberta 
Edmonton, AB T6G 2R3
Canada
Tel: +1-780-662-3826
Email: ball@ualberta.ca
2. Dr. Rajavel Elango
Assistant Professor
Department of Pediatrics
University of British Columbia
School of Population and Public Health
Child & Family Research Institute
BC Children’s Hospital
Rm 170A, 950 West 28th Avenue
Vancouver V5Z 4H4
Canada, British Columbia
Tel: +1 604-8752000 extension: 4911
Email: relango@cfri.ubc.ca
3. Dr. G. Sarwar Gilani (by Skype only)
FAOACI, FFPAS, Nutrition and Health Advisor
(Home) 506 Caracole Way, Ottawa, Ontario, 
Canada K4A 0W3
Tel:  +1-613-424-6406
Email:  galanisarwar@rogers.com
Formerly:
Senior Research Scientist
Nutrition Research Division
Health Products and Food Branch
Health Canada, Government of Canada
4. Dr. Wouter H. Hendriks
Professor of Animal Nutrition
Wageningen Campus, Building 122
De Elst 1, 6708 WD Wageningen
P.O. Box 338, 6700 AH, The Netherlands
Tel: +31 317 482290
Email: wouter.hendriks@wur.nl
5. Dr. Anura V. Kurpad 
Professor and Head, Division of Nutrition
St. John’s Research Institute
St. John’s National Academy of Health Sciences 
Bangalore-560 034, 
Kamataka, India
Tel: +91-8049466321
Fax: +91-8025501088
Email : a.kurpad@sjri.res.in 
6. Dr. Joe Millward 
Emeritus Professor of Human Nutrition
University of Surrey 
Guildford, Surrey, United Kingdom GU2 7XH 
(Home) 28 Orchard Road, Twickenham
Middlesex TW1 1LY, UK
Tel: +44-1483689297
Mobile: +44 07909 928623
Email: D.Millward@surrey.ac.uk
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7. Dr. Paul J. Moughan
Distinguished Professor and Co-Director
Riddet Institute (PN 445)
Massey University
Private Bag 11222, Palmerston North
New Zealand
Tel: +64 (0)6-3505560, 
Fax: +64 (0)6-3505655
Email: P.J.Moughan@massey.ac.nz
8. Tom Preston, 
Professor of Stable Isotope Biochemistry, 
Stable Isotope Biochemistry Laboratory,
Scottish Universities Environmental 
Research Centre,
Rankine Avenue,
Scottish Enterprise Technology Park,
East Kilbride, Glasgow G75 0QF
Scotland, UK
Tel: +44-(0)-1355-270108
Fax: +44-(0)-1355-229898
Email: Tom.Preston@glasgow.ac.uk 
9. Dr. Daniel Tomé
Professor of Human Nutrition
AgroParisTech
16 rue Claude Bernard
75005 Paris, France
Tel +33-144081718
Fax +33-144087248
Email: tome@agroparistech.fr
10. Dr. Ricardo Uauy
Professor of Pediatrics, Department of Pediatrics
Pontifi cal Catholic University, Santiago 
Chile. 
&
Professor Public Health Nutrition
London School of Hygiene and Tropical 
Medicine
University of London, London, UK
(Formerly Professor, Institute of Nutrition 
and Food Technology (INTA)
University of Chile, Santiago, Chile
Tel: 1- 214 329 1550
Email: druauy@gmail.com
FAO Secretariat
• Janice Albert, Ph.D.
Nutrition Division (ESN)
Economic and Social Development 
Department
Food and Agriculture Organization of 
the United Nations
Viale delle Terme di Caracalla
00153 Rome, Italy
Tel: 39 06 570 53552
Email: janice.albert@fao.org 
• Robert Weisell, Ph.D.
FAO International Consultant/Advisor
Viale delle Ginestre 8
Ariccia (RM) 00040, Italy
Tel: +39-339 8755863
Email: rcweisell@gmail.com; 
robert.weisell@fao.org
• Warren T. K. Lee, Ph.D.
Senior Nutrition Offi cer
Nutrition Division (ESN)
Economic and Social Development 
Department
Food and Agriculture Organization of 
the United Nations
Viale delle Terme di Caracalla
00153 Rome, Italy
Tel: 39 06 570 54077
Email: warren.lee@fao.org
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St John’s Research Institute (SJRI) 
Secretariat
• Dr. Tony Raj (Administrative representative)
Vice Dean – SJRI
St. John’s Research Institute
Bangalore - 560 034; India
Tel: +91 80 4946 7057
Fax: +91 80 25501088
Email: tonyraj@sjri.res.in 
• Dr. Indu Mani 
Adjunct Professor of Nutrition St John’s 
Research Institute
Bangalore - 560 034; India
• Deepak Thounaojam, Strategic &      
Planning Manager
Email: deepakt@stjohns.in
•  Dr. Kedar Radhakrishna, Sr. Resident
Email: kedar@sjri.res.in
• Dr. Dhinagaran, Sr. Resident
Email: dhina@sjri.res.in
• Dr. Ryan Fernandez, Sr. Resident 
Email: ryan@sjri.res.in
Observer
• Christine Slater, Ph.D.
Nutrition Specialist
Nutritional and Health-related 
Environmental Studies Section
Division of Human Health
Department of Nuclear Sciences and 
Applications
International Atomic Energy Agency
Vienna International Centre, PO Box 
100, 1400 Vienna, Austria
Email: C.Slater@iaea.org | T: (+43-1) 
2600-26059 | F: (+43-1) 26007
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Annex 6:
FAO Technical Workshop on Pro tein 
Quality Evaluation
Call For Experts
As follow up to the 2011 review of dietary protein quality evaluation in human nutrition*, FAO is 
in the process of identifying experts to participate in a working group to further consider a crucial 
issue from the 2011 review and to provide recommendations on the best methods to measure 
and predict digestion and effi ciency of utilization of protein and amino acids in humans.
Experts would be expected to participate in a four day meeting at St. John’s Research Institute, 
Bangalore, India in early March 2014 (dates to be determined).
Applicants should meet the following general criteria:
• Advanced University/College degree in nutrition science, food science, or related fi elds or a 
medical degree
• Experience with in vitro/in vivo models/assays for the digestion and effi ciency of utilization 
of protein and amino acids 
• Scientifi c publications in peer-reviewed journals, in particular, relevant publications within 
the most recent ten years
• Good knowledge of the English language, both written and oral.
• Leadership or invited participation in national or international scientifi c bodies, committees, 
and other expert advisory bodies pertinent to the scope of this work is desirable
• Experience with determination of requirements of protein and amino acids in humans.
Selection of experts
FAO places great value on the technical quality and independence of the participating experts as 
well as on the transparency of its selection process.  FAO has a procedure for selecting experts 
that promotes the excellence and independence of opinions provided.
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Applicants’ curriculum vitae will be reviewed on the basis of the criteria listed above by 
a selection panel consisting of three or more individuals including at least two independent, 
internationally recognized external experts appointed by FAO.  In selecting experts FAO will 
consider, in addition to scientifi c and technical excellence in the topic of the review, balanced 
geographic representation, including developing and developed countries, as well as gender. 
Selected experts may be requested to assist in the preparation of background papers.
Appointment of experts
The experts will be invited to contribute only in their individual scientifi c capacity.  An expert will 
not represent the government of country of which he or she is a citizen, or the institution with 
which he or she is associated.  The experts designated will not receive any remuneration; however, 
travel costs, subsistence allowance and other related expenses will be the exclusive responsibility 
of FAO.
Applications
Interested applicants should submit their curriculum vitae (CV) to the FAO Nutrition Division, at 
the address provided below.  
Your CV should include a description of education and work experience and a list of 
peer- reviewed publications relevant to the factors indicated above (please do not include reprints 
in your submission unless specifi cally requested at a later date).  
Before participating in any related activity, the selected experts will be required to declare all 
interests associated with the subjects that will be evaluated through completion of a standard 
form developed by FAO.  You will be asked to indicate in writing any interest (fi nancial and 
intellectual) on your part or that of your spouse that may affect your scientifi c independence as 
an expert, including one or more of the following conditions: employment (past or present) by 
any commercial enterprise or private or civil sector association; a recipient of research or other 
study grants from such enterprises or associations; or shareholdings in commercial enterprises 
active in fi elds related to nutrition.  These declarations will be evaluated and retained by the 
FAO Secretariat.  In addition, a confi dentiality undertaking is also to be signed to ensure proper 
handling of dossiers and proprietary information.
Deadline
Applications should be sent to FAO by 17 January 2014.  
*Link to the Report of an FAO Expert Consultation on dietary protein quality evaluation in human 
nutrition and the two subcommittee reports): http://www.fao.org/ag/humannutrition/35978-
02317b979a686a57aa4593304ffc17f06.pdf
http://www.fao.org/ag/humannutrition/nutrition/63158/en/
Annex 6
FAO Book 14-02-15.indb   49 2/14/2015   2:08:16 PM
50
Send applications and queries to: 
Janice Albert, PhD
Nutrition Offi cer
Nutrition Division C242
Food and Agriculture Organization of the United Nations
Viale delle Terme di Caracolla
00153 Rome, Italy
Telephone: +39 06 570 53552
Fax: +39 06 570 54593
IT IS PREFERABLE TO SEND THE APPLICATION BY E-MAIL IF POSSIBLE.  
Email: janice.albert@fao.org
December 2013
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